# Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

> **NCT00012246** · PHASE2 · TERMINATED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 7 (actual)

## Conditions studied

- Colorectal Cancer
- Esophageal Cancer
- Extrahepatic Bile Duct Cancer
- Gallbladder Cancer
- Gastric Cancer
- Pancreatic Cancer
- Small Intestine Cancer

## Interventions

- **BIOLOGICAL:** carcinoembryonic antigen peptide 1-6D
- **BIOLOGICAL:** incomplete Freund's adjuvant
- **BIOLOGICAL:** sargramostim

## Key facts

- **NCT ID:** NCT00012246
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Administratively Terminated
- **Last updated:** 2013-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00012246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00012246, "Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00012246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*